Level Zero Health

Executive Summary

Level Zero Health is a San Francisco-based digital health startup founded in 2020, pioneering a wearable device for continuous, real-time hormone monitoring. The company leverages proprietary DNA-based sensors and nanotechnology to measure hormone levels in interstitial fluid, offering a minimally invasive alternative to traditional blood tests. This technology aims to unlock dynamic hormonal data for applications in fertility tracking, personalized medicine, and general wellness. Currently in the pre-clinical stage, Level Zero Health is focused on sensor validation and prototype development, having not yet disclosed total funding or valuation. The company operates at the intersection of AI/machine learning and digital health, with potential to disrupt the $20B+ endocrinology diagnostics market. While still early-stage, its unique approach to non-invasive continuous monitoring positions it to address significant unmet needs in hormonal health management, provided it can navigate technical and regulatory challenges.

Upcoming Catalysts (preview)

• Q1 2026Seed or Series A Funding Round Announcement60% success
• Q2 2026Peer-Reviewed Publication of Sensor Validation Data40% success
• Q3 2026Strategic Partnership with Fertility or Wellness Platform30% success